Rodatristat ethyl 600 mg BID ( DrugBank: - )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
86 | 肺動脈性肺高血圧症 | 1 |
86. 肺動脈性肺高血圧症
臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04712669 (ClinicalTrials.gov) | March 15, 2021 | 12/1/2021 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension | Drug: rodatristat ethyl 300 mg tablet BID;Drug: rodatristat ethyl 600 mg BID;Drug: Placebo | Altavant Sciences GmbH | NULL | Recruiting | 18 Years | N/A | All | 90 | Phase 2 | Austria;United States;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Czechia;France;Germany;Italy;Latvia;Moldova, Republic of;Poland;Serbia;Spain;Ukraine;United Kingdom |